Quotient, buoyed by Covid-19 work, buys Arcinova in effort to build end-to-end CDMO brand

Flush with cash from Covid-19 work, contract manufacturers are having their own M&A mini-boom. Now, a UK-based manufacturing services firm is snagging another company headquarter on the Isles, looking to set up an end-to-end offering for customers.

Nottingham drug developer and manufacturing accelerator Quotient announced plans this week to buy Arcinova, another contract developer with over four decades in the industry.